Erratum
for Zhanel et al., Antimicrob. Agents Chemother. 47 (6) 1867-1874.
Previous Article
Antimicrobial Agents and Chemotherapy, August 2003, p. 2716, Vol. 47, No. 8
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.8.2716.2003
Antimicrobial Resistance in Respiratory Tract Streptococcus pneumoniae Isolates: Results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002
George G. Zhanel,1,2,3 Lorraine Palatnick,3 Kimberly A. Nichol,1,3 Tracy Bellyou,3 Don E. Low,4 The Cross Study Group, and Daryl J. Hoban1,3
Department of Medical Microbiology, Faculty of Medicine, University of Manitoba,1
Departments of Medicine,2
Clinical Microbiology Health Sciences Centre, Winnipeg, Manitoba,3
Mount Sinai Hospital, Toronto, Ontario, Canada4
Volume 47, no. 6, p. 1867-1874, 2003. Page 1867: The article byline should read as given above.
Page 1872, Table 6, 1998-1999: "FQR" should read "FQr," and FQr data for British Columbia, Saskatchewan, Manitoba, Quebec, Maritimes, and total for Canada should read 0.6, 1.1, 1.0, 0.9, 0.9, and 1.1, respectively.
Page 1871, Table 5: The data for TMP-SMX and levofloxacin should read as given below.
| Antibiotic and yr |
No. of
isolates |
% of isolates for which MICs
(µg/ml) were:
|
0.12 |
0.25 |
0.5 |
1 |
2 |
4 |
8 |
16 |
16 |
32 |
|
| TMP-SMX |
|
|
|
|
|
|
|
|
|
|
|
| 1997-1998 |
1,180 |
60.8 |
11.5 |
5.7 |
4.3 |
3.8 |
9.8 |
3.1 |
|
0.8 |
|
| 1998-1999 |
1,333 |
53.3 |
19.1 |
5.7 |
3.7 |
4.0 |
10.0 |
3.8 |
|
0.5 |
|
| 1999-2000 |
1,593 |
52.4 |
22.2 |
5.8 |
4.5 |
2.2 |
8.7 |
4.1 |
|
0.3 |
|
| 2000-2001 |
1,435 |
38.4 |
20.8 |
14.8 |
5.7 |
3.9 |
5.8 |
4.6 |
|
5.8 |
|
| 2001-2002 |
1,450 |
21.5 |
24.1 |
30.3 |
4.2 |
3.4 |
1.1 |
8.4 |
|
6.9 |
|
| Levofloxacin |
|
|
|
|
|
|
|
|
|
|
|
| 1997-1998 |
1,180 |
1.6 |
2.4 |
26.8 |
64.0 |
4.7 |
0.3 |
0.1 |
0.1 |
|
|
| 1998-1999 |
1,333 |
1.5 |
5.3 |
22.0 |
67.1 |
3.5 |
0.2 |
0.3 |
0.2 |
|
|
| 1999-2000 |
1,593 |
1.3 |
2.2 |
12.9 |
77.2 |
5.3 |
0.1 |
0.4 |
0.2 |
|
0.4 |
| 2000-2001 |
1,435 |
1.5 |
6.5 |
33.4 |
53.8 |
5.1 |
0.1 |
0.1 |
0.6 |
|
|
| 2001-2002 |
1,450 |
1.0 |
0.5 |
28.2 |
63.8 |
4.2 |
0.2 |
0.6 |
0.2 |
|
0.1 |
|
Antimicrobial Agents and Chemotherapy, August 2003, p. 2716, Vol. 47, No. 8
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.8.2716.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Smith, H. J., Walters, M., Hisanaga, T., Zhanel, G. G., Hoban, D. J.
(2004). Mutant Prevention Concentrations for Single-Step Fluoroquinolone-Resistant Mutants of Wild-Type, Efflux-Positive, or ParC or GyrA Mutation-Containing Streptococcus pneumoniae Isolates. Antimicrob. Agents Chemother.
48: 3954-3958
[Abstract]
[Full Text]